Fiji Kava Limited

ASX:FIJ ISIN:AU0000028359

Fiji Kava LtdFiji Kava Limited (ASX: FIJ) is an Australian-Fijian medicinal kava health & wellness company, producing natural 'noble kava' products for the complementary and alternative medicine market, estimated to exceed USD $210 billion by 2026 globally. As the first foreign company with approval from the Fijian Government to operate in the kava industry, FijiKava has established a global leading sustainable and 100% traceable, certified organic supply chain of 'noble kava' including a nucleus farm in Levuka, on the island of Ovalau, Fiji. 

FijiKava is focused on expanding the availability of noble kava products throughout western markets to provide a natural alternative to prescription medicines to promote sleep, soothe and calm the nerves, support muscle relaxation and relax the mind.

 
    

News

Fiji Kava Limited (ASX:FIJ) Board Change and Annual General Meeting Update

🕔11/28/2022 8:14:24 AM 555

Fiji Kava Limited (ASX:FIJ) advises that Mr Nicholas Simms has retired by rotation as a Director of Fiji Kava Ltd and all subsidiaries.

Read Full Article

Fiji Kava Limited (ASX:FIJ) Leilo Dietary Shots to be sold through The Vitamin Shoppe

🕔11/22/2022 10:47:07 AM 629

Fiji Kava Limited (ASX:FIJ) an Australian-Fijian medicinal Kava company which produces products for the natural medicine market has confirmed the nationwide listing of their dietary shots range across Vitamin Shoppe nationally in the USA, in April 2023.

Read Full Article

Fiji Kava Limited (ASX:FIJ) Investor Webinar

🕔10/4/2022 8:08:31 AM 797

Fiji Kava Limited (ASX:FIJ), a health and wellness company with operations in Australia, Fiji, and the USA, is pleased to invite shareholders and investors to a webinar on Thursday 06 October 2022 at 10:30am AEDT / 7:30am AWST.

Read Full Article

Fiji Kava Limited (ASX:FIJ) Fiji Kava to Acquire Leilo and Completion of Placement

🕔10/3/2022 10:49:49 AM 1176

Fiji Kava Limited (ASX:FIJ) has entered into a binding agreement to acquire Leilo Inc, in all stock acquisition and has completed a placement of $1.6m to sophisticated and institutional investors.

Read Full Article

Fiji Kava Limited (ASX:FIJ) Annual Report to Shareholders

🕔10/3/2022 9:24:29 AM 706

Fiji Kava Limited (ASX:FIJ) is a medicinal kava company based in Australia and the first foreign company with approval from the Fijian Government to operate in the kava industry.

Read Full Article

Fiji Kava Limited (ASX:FIJ) James Dack joins Board to Support US Growth

🕔9/29/2022 11:38:08 AM 1456

Fiji Kava Limited (ASX:FIJ) an Australian-Fijian medicinal Kava company with operations across the USA, which produces nutraceutical and beverage products for the natural medicine market, is pleased to announce the appointment of James Dack as Non-Executive Director of the Company.

Read Full Article

Fiji Kava Limited (ASX:FIJ) Quarterly Activity Report

🕔7/29/2022 3:32:25 PM 923

Fiji Kava Limited (ASX:FIJ) an Australian-Fijian medicinal Kava company which produces natural Noble Kava products for the natural medicine market, wishes to provide shareholders and investors with an overview of quarterly activities to accompany the Appendix 4C for the period ended 30 June 2022.

Read Full Article

Fiji Kava Limited (ASX:FIJ) Cost Saving Initiatives FY23

🕔7/29/2022 8:17:17 AM 1055

Fiji Kava Limited (ASX:FIJ), a health and wellness company with operations in Australia, Fiji, and the USA. The company has taken steps to lower operating cost base in response to the current challenging environment.

Read Full Article

Fiji Kava Limited (ASX:FIJ) Network Nutrition Strategic Partnership Expanded

🕔7/26/2022 8:22:32 AM 1267

Fiji Kava Limited (ASX:FIJ) is pleased to announce the extension of the strategic partnership with Network Nutrition, a specialty ingredients brand which is part of the EUR8b Dutch publicly listed multinational, IMCD.

Read Full Article

Fiji Kava Limited (ASX:FIJ) The Calmer Co. USA Update

🕔7/13/2022 9:59:33 AM 1656

Fiji Kava Limited (ASX:FIJ) advises shareholders and investors that The Calmer Co. USA led by sales via Amazon direct to consumer and Danodan direct to consumer business units, now account for more than half of the Company's global revenue.

Read Full Article
###

10,903 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 312) (Last 30 Days: 746) (Since Published: 10903) 

Company Data

    Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 
  • Homepage
  • fijikava.com

Company Reports

Presentations

Quarterly Report

Social Media